| 46708-525-25 |
46708-525 |
HUMAN PRESCRIPTION DRUG |
doxorubicin hydrochloride |
doxorubicin hydrochloride |
INJECTION, SUSPENSION, LIPOSOMAL |
INTRAVENOUS |
20250627 |
N/A |
ANDA |
ANDA219199 |
Alembic Pharmaceuticals Limited |
DOXORUBICIN HYDROCHLORIDE |
2 mg/mL |
1 VIAL, SINGLE-DOSE in 1 CARTON (46708-525-25) / 25 mL in 1 VIAL, SINGLE-DOSE |
| 62332-810-10 |
62332-810 |
HUMAN PRESCRIPTION DRUG |
doxorubicin hydrochloride |
doxorubicin hydrochloride |
INJECTION, SUSPENSION, LIPOSOMAL |
INTRAVENOUS |
20250627 |
N/A |
ANDA |
ANDA219199 |
Alembic Pharmaceuticals Inc. |
DOXORUBICIN HYDROCHLORIDE |
2 mg/mL |
1 VIAL, SINGLE-DOSE in 1 CARTON (62332-810-10) / 10 mL in 1 VIAL, SINGLE-DOSE |
| 62332-525-25 |
62332-525 |
HUMAN PRESCRIPTION DRUG |
doxorubicin hydrochloride |
doxorubicin hydrochloride |
INJECTION, SUSPENSION, LIPOSOMAL |
INTRAVENOUS |
20250627 |
N/A |
ANDA |
ANDA219199 |
Alembic Pharmaceuticals Inc. |
DOXORUBICIN HYDROCHLORIDE |
2 mg/mL |
1 VIAL, SINGLE-DOSE in 1 CARTON (62332-525-25) / 25 mL in 1 VIAL, SINGLE-DOSE |
| 46708-810-10 |
46708-810 |
HUMAN PRESCRIPTION DRUG |
doxorubicin hydrochloride |
doxorubicin hydrochloride |
INJECTION, SUSPENSION, LIPOSOMAL |
INTRAVENOUS |
20250627 |
N/A |
ANDA |
ANDA219199 |
Alembic Pharmaceuticals Limited |
DOXORUBICIN HYDROCHLORIDE |
2 mg/mL |
1 VIAL, SINGLE-DOSE in 1 CARTON (46708-810-10) / 10 mL in 1 VIAL, SINGLE-DOSE |